Enhanced Carbon Particle Therapy System for Cardiac Arrhythmia Treatment
Legal Citation
Summary of the Inventive Concept
An improved carbon particle therapy system that integrates real-time motion tracking, focused photonic therapy, and machine learning algorithms to enhance treatment accuracy, reduce collateral damage, and improve patient outcomes for cardiac arrhythmia treatment.
Background and Problem Solved
The original patent for carbon particle therapy for cardiac arrhythmia treatment had limitations in compensating for cardiac and respiratory movements, resulting in reduced treatment accuracy and increased risk of collateral damage. The new inventive concept addresses these limitations by incorporating advanced technologies to improve treatment outcomes.
Detailed Description of the Inventive Concept
The enhanced system comprises a real-time motion tracking module that adjusts radiation beam delivery in response to cardiac and respiratory movement. Additionally, the system incorporates focused photonic therapy, which enables more precise and efficient treatment. Machine learning algorithms are used to predict and compensate for movements of the targeted tissue, ensuring improved treatment outcomes and reduced side effects. The system also includes a catheter-free imaging module for providing real-time location information and electrical information of the heart during treatment, enabling more accurate and efficient therapy delivery.
Novelty and Inventive Step
The new inventive concept's integration of real-time motion tracking, focused photonic therapy, and machine learning algorithms provides a novel and non-obvious solution to the limitations of the original patent. The use of machine learning algorithms to predict and compensate for movements of the targeted tissue is a significant advancement in the field.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the use of different imaging modalities, such as MRI or CT, to provide real-time location information. Additionally, the system could be adapted for use in treating other diseases or conditions, such as cancer or neurological disorders.
Potential Commercial Applications and Market
The enhanced carbon particle therapy system has significant commercial potential in the medical device industry, particularly in the treatment of cardiac arrhythmias. The system's ability to improve treatment accuracy and reduce collateral damage could lead to increased adoption and market share in the radiation therapy market.
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Medical radiation therapy, specifically particle beam therapy for cardiac tissue treatment, requiring advanced knowledge of radiation oncology, medical imaging, motion tracking technologies, and interventional cardiology techniques
Person of Ordinary Skill (PHOSITA) Profile
A medical physicist or radiation oncology specialist with expertise in particle therapy, advanced imaging techniques, motion compensation strategies, and interdisciplinary medical technology design
Obviousness Rationale
A PHOSITA would recognize that the PTD's integration of machine learning motion tracking, focused photonic therapy, and catheter-free imaging represents predictable technological improvements to the existing particle therapy methodology disclosed in the source patent. The variations systematically address known challenges in cardiac tissue treatment by applying standard engineering problem-solving approaches. These enhancements represent incremental advancements that would be obvious to a skilled practitioner seeking to optimize particle therapy accuracy and patient outcomes.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,808 |
|---|---|
| Title | System and method for carbon particle therapy for treatment of cardiac arrhythmias and other diseases |
| Assignee(s) | Mayo Foundation for Medical Education and Research |